Subscribe & Support This Site!
consumer hair removal forum
Page 7 of 12 < 1 2 5 6 7 8 9 11 12 >
Topic Options
Rate This Topic
Hop To:
#42457 - 05/29/07 11:06 PM Re: Good news here... [Re: chrille1]
jme1 Offline
Major Contributor

Registered: 12/25/05
Posts: 91
September? Last I heard, they second round of trials was supposed to be concluded in June.

Top
Sponsored Links
#42490 - 05/30/07 05:27 PM Re: Good news here... [Re: jme1]
jeffk Offline
Contributor

Registered: 10/31/06
Posts: 41
the article can be read on their homepage on the left site
i think september is okay coz they also promise to develop a home use kit

Top
#42514 - 05/31/07 01:08 PM Re: Good news here... [Re: jeffk]
newbie133 Offline
Contributor

Registered: 08/12/06
Posts: 15
sounds prommising.. does anyone know how long it could take for this thing to hit the markets if all goes well in the clinical trails.. are we talking months after or (the one im hoping its not) yeaars later..
if anyone knows nething about this stuff please enlighten me..
thanks guys.

Top
#42641 - 06/04/07 07:58 PM Re: Good news here... [Re: newbie133]
mike856nj Offline
Major Contributor

Registered: 01/08/07
Posts: 63
Hello ALL!

I finally got some answers to the new topical solution that may one day PERMANENTLY remove hair. This is still in clinical trials, but this is the response I received:

Thank you very much for your interest in our hair removal product. Being a publicly traded Company, I restricted in disclosing many information unless accompanied by a news release. I will try to answer your question as much as possible.

1. Our fifty patient clinical trial results are not expected before September 2007.
2. Based on the mechanism of action of our product, we anticipate the product to be useful of all hair/skin types.
3. We are hoping this method to remove hair permanently; we need to get the clinical data to further confirm it.
4. In the current clinical trial we shave the hair before applying the gel.
5. The market launch date for this product for Canada and Asia will be determined upon completing the current clinical trial. Our strategic partner, Paramount Biosciences will soon be initiating development for US and Europe.
6. So far we have not noticed any side effects.
7. Prices are yet to be determined

Once again, I thank you for your interest and wish you all the best.

Regards,
Madi


Keep your fingers crossed!


Mike

Top
#43076 - 06/20/07 11:40 PM Re: Good news here... [Re: mike856nj]
mike856nj Offline
Major Contributor

Registered: 01/08/07
Posts: 63
Quest PharmaTech and Paramount BioSciences Sign Exclusive Multinational License Agreement to Develop and Commercialize SonoLight Technology for Dermatology Appl
(posted on 14/05/2007)

On this related topic
licensing agreement

92 news
EDMONTON, AB and SAN DIEGO, CA, May 14 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (“Quest”) (TSX: QPT) announced today that Paramount BioSciences, LLC, has acquired multinational rights to Quest’s proprietary SonoLight technology for dermatology applications. Paramount BioSciences is a global drug development and healthcare investment firm with a portfolio of life-sciences-focused companies. The deal gives Paramount BioSciences access to a library of Hypocrellin B-derived photosensitizers which are activated by light or ultrasound energy sources. Quest’s SonoLight photosensitizer technology is designed around Hypocrellin B, a complex small molecule isolated from a parasitic fungus (Hypocrella bambusae) normally found in Chinese bamboo trees. Multiple Hypocrellin B derivatives are available for evaluation in a wide variety of dermatology and oncology indications. The lead compound, SL017 formulated as a topical gel, has been combined with a widely available light source for permanent removal of unwanted hair and for treatment of actinic keratosis.

Under the terms of the agreement, Paramount BioSciences is responsible for dermatology-related development and commercialization activities outside of Canada. In addition, the agreement with Paramount BioSciences allows KMH Co. Ltd. to develop SL017 as a cosmetic for hair removal in Asia and acne in South Korea. In return, Quest will receive an immediate upfront payment and potential future milestone payments in excess of $35 million USD plus royalties on sales. Quest will retain Canadian rights for dermatology and worldwide rights to non-dermatology applications.

“Paramount BioSciences is very excited to be involved in the SonoLight program. We have already mobilized our in-house team to begin product development and lay the groundwork for the Paramount portfolio company that will continue development and ultimately commercialize this novel technology,” said Bertrand Liang, Vice Chairman of Paramount BioSciences.

Quest is exploring the possibility of introducing SL017 topical gel to the Canadian cosmetic market for permanent hair removal after the completion of their ongoing clinical program. KMH has recently initiated a clinical program with the objective of registering SL017 as a cosmetic product for hair removal in Korea.

“I am very pleased to have found a strategic partner like Paramount BioSciences who shares our vision in the potential of our SonoLight Technology, and has the expertise and financial resources to develop SL017 for the U.S and European markets,” said Dr. Madi R. Madiyalakan, Chief Executive Officer of Quest.

About Quest PharmaTech Inc.

—————————————-

Quest is a publicly traded (TSX Venture Exchange: QPT), Alberta-based drug development company committed to the development and commercialization of new pharmaceutical products. It is developing a series of products for the treatment of cancer and dermatological conditions based on its unique photodynamic and sonodynamic therapy platform.

Quest will continue to develop SL017 for dermatology applications for the Canadian market as well as SL052, Quest’s second product, and other compounds for worldwide oncology applications. SL052 is an injectable formulation that is in late-stage pre-clinical development for prostate cancer treatment. The practical application of SL052 photodynamic therapy treatment system on the prostate gland has already been demonstrated in a canine prostate model.

About Paramount BioSciences

—————————————-

Paramount BioSciences, LLC (http://www.paramountbio.com) is a global drug development and healthcare investment firm focused on the in-licensing of novel therapeutics, and the formation of new biotechnology companies.

Forward-Looking Statements

—————————————

Except for historical information, this press release may contain forward-looking statements, which reflect Quest’s current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in Quest’s ongoing quarterly and annual reporting.

“TSX Venture Exchange has neither approved nor disapproved of the

information contained herein.”

http://www.prnewswire.com/...
Source: PR Newswire

Top
#43603 - 07/10/07 05:24 PM More progress @Quest [Re: mike856nj]
jeffk Offline
Contributor

Registered: 10/31/06
Posts: 41
They made an agreement with a company to develop a home use light device.

http://micro.newswire.ca/43406-0.html

Top
#45549 - 09/04/07 11:51 PM Re: More progress @Quest [Re: jeffk]
Eddy Offline
Major Contributor

Registered: 07/08/06
Posts: 55
Hi all,
Shouldn't the results for Quest's clinical trial be in this month? Anyone heard anything?

Top
#45674 - 09/09/07 07:24 PM Re: More progress @Quest [Re: Eddy]
jme1 Offline
Major Contributor

Registered: 12/25/05
Posts: 91
You most likely won't hear anything until October at the earliest as they will have to analyze the results of the trial.

Top
#46305 - 10/06/07 11:18 PM Re: More progress @Quest [Re: jme1]
Eddy Offline
Major Contributor

Registered: 07/08/06
Posts: 55
Hey guys,
Quest presented at a BioSciences conference a few days ago. You can view their presentation here:

http://www.biocontact.qc.ca/english/presenters/pop-entreprise.php?compagnie=769

There are some photos of the Phase II trial underway which look promising!
Their goal is to first release SL017 to clinics and spas for use with IPL and then to market a home use device all in the next 12 months.
We have heard this before but its good to see some photo evidence at last!
Hope they can make it work.

Cheers.

Top
#46309 - 10/07/07 01:35 AM Re: More progress @Quest [Re: Eddy]
dfahey Offline

Top 10 Contributor

Registered: 10/27/03
Posts: 9634
Loc: Columbus, Ohio
Should I buy some stock so I have income when this invention puts me out of business?

I'll read this later. Thanks Eddy for watching Quest for us.
_________________________
Dee Fahey, R.N., C.T.
Licensed by the State Medical Board of Ohio for Nursing license and Cosmetic Therapy/Electrolysis license
_____________________
ELECTROLYSIS FAQ'S:

British Institute & Association of Electrolysis

http://www.electrolysis.co.uk/?page_id=16

Top
Page 7 of 12 < 1 2 5 6 7 8 9 11 12 >

Moderator:  Andrea 
Sponsored Links
Recent Posts
Anyone want 2 very old galvanic machines??
by Iluv2zap
0 seconds ago
Newbie With a Few Questions
by stoppit&tidyup
Yesterday at 05:57 AM
A Tale of Two Electrolygists
by Iluv2zap
01/21/18 01:03 PM
Back hair treatment schedule
by coolie
01/20/18 01:30 PM
Advice: Should I switch to someone who uses blend?
by Josefa M. Reina
01/20/18 06:52 AM
Top Posters
LAgirl 9994
dfahey 9633
James W. Walker VII 8052
Andrea 4149
Michael Bono 3225
Who's Online
1 registered (1 invisible), 116 Guests and 3 Spiders online.
Key: Admin, Global Mod, Mod